Studies on supportive care in oral mucositis: Random or randomised?

European Journal of Cancer

Volumn 37, Issue 16, 2001, Pages 1971-1975

  Van der Rijt, C C D ^a   Van Zuijlen, L ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CHLORHEXIDINE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; HYDROCORTISONE; ICE; METHYLCELLULOSE; MYELOABLATIVE AGENT; NARCOTIC AGENT; PILOCARPINE; POVIDONE IODINE; SUCRALFATE; TETRACAINE;

ANEMIA; BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL; CYTOTOXICITY; DISEASE SEVERITY; DRUG INDUCED DISEASE; HEAD CANCER; HOSPITAL CHARGE; HUMAN; LEUKOPENIA; MOUTH HYGIENE; MUCOSA INFLAMMATION; NAUSEA; NECK CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; VOMITING; XEROSTOMIA;

EID: 0034779285     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00248-9     Document Type: Editorial

References (24)

1. Interventions for preventing oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy (excluding head and neck cancer)
2. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation
3. Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients
4. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: Results of a prospective randomised trial
5. Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis
6. Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer
7. Comparison of methods to determine the prevalence and nature of oral mucositis
8. Validation of a new scoring system for assessment of clinical trials research of oral mucositis induced by radiation or chemotherapy
9. The PRO-SELF mouth aware program: An effective approach for reducing chemotherapy-induced mucositis
10. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy
11. Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis
12. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomised controlled trial comparing two protocols of dental care
13. Granulocyte and granulocyte-macrophage colony stimulating factors induce human endothelial cells to migrate and proliferate
14. Characterization of human GM-CSF receptors on non-hematopoietic cells
15. Phase III randomised double blind placebo controlled trial of rh GM-CSF following allogenic bone marrow transplant
16. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil and leucovorin chemotherapy
17. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: A prospective randomized study
18. Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: A randomized, double-blind, dose-ranging study
19. Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: A prospective placebo-controlled double blind study
20. Risk factors for chemotherapy-induced oral mucositis: Dental appliances, oral hygiene, previous oral lesions, and history of smoking
21. The oral flora as a source of septicemia in patients with acute leukemia
22. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer
23. A multicenter, randomized, double-blind placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation induced xerostomia in head and neck patients
24. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer